1
|
Kim D, Yoon H, Kim S, Wi J, Chae H, Jo G, Yoon JY, Kim H, Lee C, Kim SH, Hong HJ. Generation of a Human Monoclonal Antibody to Cross-Reactive Material 197 (CRM₁₉₇) and Development of a Sandwich ELISA for CRM₁₉₇ Conjugate Vaccines. J Microbiol Biotechnol 2019; 28:2113-2120. [PMID: 30380821 DOI: 10.4014/jmb.1810.10009] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
Abstract
Cross-reactive material 197 (CRM₁₉₇) is a non-toxic mutant of diphtheria toxin containing a single amino acid substitution of glycine 52 with glutamic acid. CRM₁₉₇ has been used as a carrier protein for poorly immunogenic polysaccharide antigens to improve immune responses. In this study, to develop a sandwich ELISA that can detect CRM₁₉₇ and CRM₁₉₇ conjugate vaccines, we generated a human anti-CRM₁₉₇ monoclonal antibody (mAb) 3F9 using a phage-displayed human synthetic Fab library and produced mouse anti-CRM₁₉₇ polyclonal antibody. The affinity (KD) of 3F9 for CRM₁₉₇ was 3.55 nM, based on Bio-Layer interferometry, and it bound specifically to the B fragment of CRM₁₉₇. The sandwich ELISA was carried out using 3F9 as a capture antibody and the mouse polyclonal antibody as a detection antibody. The detection limit of the sandwich ELISA was <1 ng/ml CRM₁₉₇. In addition, the 3F9 antibody bound to the CRM₁₉₇-polysaccharide conjugates tested in a dose-dependent manner. This ELISA system will be useful for the quantification and characterization of CRM₁₉₇ and CRM₁₉₇ conjugate vaccines. To our knowledge, this study is the first to generate a human monoclonal antibody against CRM₁₉₇ and to develop a sandwich ELISA for CRM₁₉₇ conjugate vaccines.
Collapse
Affiliation(s)
- Dain Kim
- Department of Systems Immunology, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea
| | - Hyeseon Yoon
- Eubiologics Co., Ltd., Chuncheon 24232, Republic of Korea
| | - Sangkyu Kim
- Department of Systems Immunology, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea
| | - Jimin Wi
- Scripps Korea Antibody Institute, Chuncheon 24341, Republic of Korea
| | - Heesu Chae
- Department of Systems Immunology, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea
| | - Gyunghee Jo
- Department of Systems Immunology, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea
| | - Jun-Yeol Yoon
- Department of Systems Immunology, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea
| | - Heeyoun Kim
- Eubiologics Co., Ltd., Chuncheon 24232, Republic of Korea
| | - Chankyu Lee
- Eubiologics Co., Ltd., Chuncheon 24232, Republic of Korea
| | - Se-Ho Kim
- Department of Systems Immunology, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea
| | - Hyo Jeong Hong
- Department of Systems Immunology, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea.,Scripps Korea Antibody Institute, Chuncheon 24341, Republic of Korea
| |
Collapse
|